Compliance & Medical Disclaimer

This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.

IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.

Reviewed by: WolveStack Research Team
Last reviewed: 2026-04-28
Editorial policy

Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.

Medical Disclaimer

For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.

Standard ipamorelin dosing ranges from 200-300 micrograms administered 2-3 times daily via subcutaneous injection, typically for 8-12 week cycles. Most users inject on an empty stomach before bed to align with natural GH release patterns. Common protocol combines ipamorelin with CJC-1295 (GHRH) for synergistic GH stimulation. Reconstitution requires bacteriostatic water at 1:1 ratio, stored refrigerated. Optimal dosing depends on response, body composition, and concurrent compounds.

What Is the Standard Ipamorelin Dosage?

The most commonly recommended ipamorelin dosage in the research community is 200-300 micrograms per injection, administered 2-3 times daily via subcutaneous injection. This dosage range appears in most research protocols and community discussions. The first dose typically occurs on an empty stomach, ideally before bed, to maximize alignment with natural growth hormone pulsatile release. Timing is critical: ipamorelin works by stimulating endogenous GH secretion, which follows circadian patterns with major pulses during early sleep stages.

Beginners often start at the lower end (200 mcg once daily) to assess tolerance, then progress to 2-3 daily injections. Advanced users may increase to 300-400 mcg per injection if seeking maximal GH stimulation, though evidence suggests diminishing returns beyond 300 mcg. The 2-3 daily injection protocol mimics natural GH pulse frequency more accurately than single daily dosing.

Reconstitution and Storage Protocol

Ipamorelin arrives as a lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before use. The reconstitution ratio is typically 1 ml bacteriostatic water per 1 mg ipamorelin powder, creating a solution where 100 units on an insulin syringe equals 10 mcg. This standard ratio simplifies dosing calculations and is consistent across most research peptide suppliers.

Storage is critical: reconstituted ipamorelin must be refrigerated (2-8°C) immediately and remains stable for approximately 30 days. Unopened, undiluted powder vials stored at -20°C remain viable for 1-2 years. Never freeze reconstituted solution, as ice crystal formation damages the peptide structure. Always use sterile, fresh bacteriostatic water from sealed vials to prevent contamination.

Injection Timing for Maximum GH Response

Ipamorelin's effectiveness depends critically on timing. The peptide triggers GH release over 30-60 minutes, peaking around 60-90 minutes post-injection. For maximal effect, injections should occur on an empty stomach (minimum 2 hours after eating, ideally 3-4 hours). This fasting state enhances the GH secretory response by 30-50% compared to fed conditions.

The ideal injection window is 30-60 minutes before bed, allowing peak GH release to coincide with early sleep stages when natural GH secretion is highest. This synchronization amplifies the growth hormone signal. Some practitioners split doses between morning (pre-breakfast) and evening (pre-bed), spaced 8-12 hours apart, to maintain more consistent circulating GH levels throughout the day.

Cycle Length and Off-Cycle Protocols

Standard ipamorelin cycles last 8-12 weeks, with 8-10 weeks being most common. This duration allows sufficient time to observe muscle growth, fat loss, and recovery improvements while minimizing tolerance development. The pituitary's GH-releasing capacity doesn't meaningfully downregulate with ipamorelin (unlike with continuous exogenous GH), but extending cycles beyond 12 weeks offers diminishing returns.

Off-cycle protocols vary: some practitioners take 2-4 week breaks between cycles to allow any minor downregulation to reverse, while others run year-round at lower doses. Most evidence suggests continuous use is safe, as ipamorelin doesn't cause the pituitary suppression associated with exogenous testosterone or other hormones. However, periodic breaks (every 12-16 weeks) may optimize long-term responsiveness.

Stacking Ipamorelin with CJC-1295 for Synergy

The ipamorelin + CJC-1295 stack is considered the gold standard GH secretagogue protocol. Ipamorelin acts as a GH-releasing peptide (GHRP), stimulating pituitary somatotroph cells. CJC-1295 is a GHRH analog that extends GH-releasing hormone signaling. Together, they target both major GH control pathways: CJC provides the 'push' signal (GHRH), while ipamorelin removes the 'brake' (somatostatin inhibition) and provides additional stimulation.

Typical stacking dosage: 200-300 mcg ipamorelin combined with 100 mcg CJC-1295, injected simultaneously 2-3 times daily. This combination produces GH responses 2-3x higher than ipamorelin alone, without the hunger stimulation of GHRP-6 or the prolactin/cortisol dysregulation of GHRP-2. The synergy makes this stack uniquely effective for muscle growth and body composition.

Dose Adjustments Based on Response and Body Composition

Optimal ipamorelin dosing should be personalized based on individual response. Some users see excellent results at 150-200 mcg, while others require 300+ mcg for maximal effect. Initial assessment requires 1-2 weeks at starting dose before judging efficacy. If minimal growth or recovery improvements are observed after 2 weeks, increase to the next dose level.

Heavier or more muscular individuals often require higher doses (250-300+ mcg) due to greater GH requirements for anabolic effects. Conversely, lighter or less experienced lifters may see excellent results at 150-200 mcg. Stacking with testosterone or other anabolic compounds may require higher ipamorelin doses to match their anabolic signaling. Monitor response over weeks 4-8 and adjust accordingly.

Common Dosing Mistakes and How to Avoid Them

The most frequent error is injecting too soon after meals. Any stomach content significantly blunts the GH response. Maintain strict 2-3 hour minimum fasts before injection. Second mistake: inadequate reconstitution water volume, creating overly concentrated solutions that may degrade peptide potency. Always use fresh, sealed bacteriostatic water bottles, never reused containers.

Third error: inconsistent injection timing. Varying injection times by hours disrupts the pulsatile GH pattern you're trying to establish. Set consistent injection times and maintain them ±30 minutes daily. Fourth mistake: single daily dosing expecting maximum results. Once-daily ipamorelin produces 30-40% lower GH response than 2-3 daily injections due to pituitary accommodation. Use multiple daily doses for optimal efficacy.

Reconstitution Calculations and Syringe Measurements

Standard calculation: 1 mg ipamorelin + 1 ml bacteriostatic water = 1 mg/ml solution. On a 100-unit insulin syringe, each unit mark represents 0.01 ml. Therefore: 1 unit insulin syringe = 10 mcg ipamorelin. To administer 200 mcg, draw 20 units on the syringe. To administer 300 mcg, draw 30 units.

Always double-check your math before injecting. Some practitioners prefer pre-drawn syringes marked with dosage levels to eliminate calculation errors. Store syringes in the refrigerator, capped with sterile needles. Reconstituted solution in pre-filled syringes remains stable approximately 30 days when refrigerated. Date all vials upon reconstitution to track freshness.

Comparative Analysis: Ipamorelin vs Other GH Secretagogues by Dosage

Compared to GHRP-2 (which requires 100-200 mcg), ipamorelin at 200-300 mcg produces similar GH responses with superior safety (no prolactin/cortisol elevation). GHRP-6 at similar doses causes intense hunger; ipamorelin is appetite-neutral. Compared to CJC-1295 alone (which requires 100 mcg), ipamorelin produces more acute GH spikes. Hexarelin at 100 mcg produces faster GH peaks but causes more pronounced tachyphylaxis (tolerance).

Ipamorelin's sweet spot is 200-300 mcg because it balances GH efficacy with safety and consistency. Higher doses don't proportionally increase GH release; instead, they increase injection frequency costs and potential injection site irritation without meaningful benefit gain. This is why 200-300 mcg 2-3x daily remains the most widely used protocol.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Particle Peptides

Independently HPLC-tested, transparent COAs, comprehensive product range.

Browse Particle Peptides →

Limitless Life Nootropics

Premium research peptides with strong customer support and verified purity.

Browse Limitless Life →

Frequently Asked Questions

Can I use ipamorelin daily long-term?

Yes. Ipamorelin doesn't suppress the pituitary or create tolerance patterns like exogenous GH. Most practitioners use it continuously or in 12-16 week cycles.

Will higher doses accelerate results?

Beyond 300 mcg, GH response plateaus. Increases beyond this don't produce proportional benefit and waste peptide.

What if I miss a dose?

Single missed doses have minimal impact. Resume normal schedule at the next dose. Don't double-dose to compensate.

Can I freeze reconstituted ipamorelin?

Never. Freezing damages the peptide irreversibly. Refrigerate only (2-8°C).

How do I calculate dosing with different reconstitution ratios?

The standard is 1:1 (1 mg peptide to 1 ml water). If using different ratio, recalculate accordingly: 2:1 would mean 1 mg peptide in 2 ml water creates 0.5 mg/ml concentration.

Is reconstituted ipamorelin stable at room temperature?

No. Bacterial growth and peptide degradation occur rapidly at room temperature. Refrigeration is mandatory for stability.